Daylla 3 mg/0,02 mg filmom obložene tablete
Name | Daylla 3 mg/0,02 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-320765811 |
Active Substance | drospirenon etinilestradiol |
Composition | jedna filmom obložena tableta sadrži 3 mg drospirenona i 0,02 mg etinilestradiola |
Pharmaceutical Form | filmom obložena tableta |
Packaging [MA Number for Packaging] | 28 tableta u blisteru, u kutiji [HR-H-320765811-01] 84 tablete u blisteru, u kutiji [HR-H-320765811-02] 168 tableta u blisteru, u kutiji [HR-H-320765811-03] 364 tablete u blisteru, u kutiji [HR-H-320765811-04] |
Manufacturer | Gedeon Richter Plc., Budimpešta, Mađarska |
Marketing Authorisation Holder | Gedeon Richter Plc., Gyömrői út 19-21, Budimpešta, Mađarska |
Marketing Authorisation Date | 12.02.2021 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/18-02/272 |
Registration Number | 381-12-01/70-21-03 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | G03AA12 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |
Educational materials for healthcare professionals |
Lista provjere za propisivača verzija 1 |
Educational materials for patients / caregivers |
Važne informacije za korisnice verzija 1 |